The site is an early drug discovery research centre with a track record of generating a succession of products in the areas of anaesthesia and psychiatry.

In 2007, the Royal Society of Chemistry Malcolm Campbell Memorial Prize was awarded to researchers for its work on a new anaesthesia drug, sugammadex.

[1][failed verification] It currently employs 250 scientists across a range of disciplines including medicinal chemistry, molecular biology and drug metabolism.

[7] The site has a long history of research in the area of neuromuscular blockers, which are commonly used during surgery, and was responsible for the identification of rocuronium as well as a number of other drugs.

More recently the site was closely involved in supporting the introduction of the anti-psychotic asenapine which has just been launched for the treatment of schizophrenia and bipolar disorder.